UA114639U - METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME - Google Patents

METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME

Info

Publication number
UA114639U
UA114639U UAU201610331U UAU201610331U UA114639U UA 114639 U UA114639 U UA 114639U UA U201610331 U UAU201610331 U UA U201610331U UA U201610331 U UAU201610331 U UA U201610331U UA 114639 U UA114639 U UA 114639U
Authority
UA
Ukraine
Prior art keywords
children
day
capsule
adolescents
dysfunction syndrome
Prior art date
Application number
UAU201610331U
Other languages
Ukrainian (uk)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to UAU201610331U priority Critical patent/UA114639U/en
Publication of UA114639U publication Critical patent/UA114639U/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Спосіб лікування вторинних кардіоміопатій у дітей та підлітків на фоні синдрому вегетативної дисфункції включає застосування засобів традиційної базової терапії та метаболічних засобів. Як метаболічний засіб призначають пероральне використання комбінованого препарату ритмокор у капсулах, за 10-15 хвилин до вживання їжі, запиваючи їх невеликою кількістю води, дітям від 3 до 6 років по 1 капсулі 2 рази на добу, дітям 6-12 років по 1 капсулі 3 рази на добу. При досягненні терапевтичного ефекту (через 5-7 діб) дозу препарату зменшують до прийому 1 капсули 2 рази на добу протягом часу достатнього для одержання позитивного ефекту.A method of treating secondary cardiomyopathies in children and adolescents against a background of autonomic dysfunction syndrome involves the use of traditional basic therapy and metabolic agents. As a metabolic agent is prescribed oral use of the combined drug rhythmcor in capsules, 10-15 minutes before eating, drinking them with a small amount of water, children from 3 to 6 years 1 capsule 2 times a day, children 6-12 years 1 capsule 3 times a day. Upon reaching the therapeutic effect (5-7 days) the dose of the drug is reduced to 1 capsule twice a day for a time sufficient to produce a positive effect.

UAU201610331U 2016-10-10 2016-10-10 METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME UA114639U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201610331U UA114639U (en) 2016-10-10 2016-10-10 METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201610331U UA114639U (en) 2016-10-10 2016-10-10 METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME

Publications (1)

Publication Number Publication Date
UA114639U true UA114639U (en) 2017-03-10

Family

ID=58504416

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201610331U UA114639U (en) 2016-10-10 2016-10-10 METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME

Country Status (1)

Country Link
UA (1) UA114639U (en)

Similar Documents

Publication Publication Date Title
RU2017134443A (en) METHOD OF TREATMENT WITH USE OF TRADIPTANT
CO2020000939A2 (en) Dihydroergotamine Nasal Dosage Forms
MX2017006938A (en) Combination therapy for treatment of cancer.
MX2023000187A (en) Dosing of vibegron for treatment of overactive bladder.
MX2020001768A (en) Methods of treatment of osteoarthritis with transdermal cannabidiol gel.
MX2022015629A (en) Use of vibegron to treat overactive bladder.
EA202090242A1 (en) TREATMENT OF FABRY DISEASE IN FZT-NAIVE AND FZT-TREATED PATIENTS
ECSP17019893A (en) ANAMORELIN-BASED MEDICAL TREATMENTS
CL2018002734A1 (en) Vitamin D treatment methods
MX2021002322A (en) Novel methods.
AR102308A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OR PREVENTION OF VITAMIN AND MINERAL DEFICIENCIES IN PATIENTS SUBJECTED TO GASTRIC BYPASS SURGERY
MX2018009867A (en) Methods comprising fixed intermittent dosing of cediranib.
UA114639U (en) METHOD OF TREATMENT OF SECONDARY CARDIOMYOPATHIES IN CHILDREN AND ADOLESCENTS ON VEGETABLE DYSFUNCTION SYNDROME
EA201891860A1 (en) PHARMACEUTICAL COMPOSITION OF PROLONGED SURVIVAL, CONTAINING CYSTEMINE OR ITS SALT
RU2010153722A (en) METHOD FOR INCREASING EFFECTIVENESS OF TREATMENT OF HYPOFUNCTIONS OF OVARIES IN COWS
MX2021004138A (en) Methods and formulations for treating chemotherapy-induced nausea and vomiting.
ATE501724T1 (en) LECTIN COMPOSITION FOR THE PROPHYLAXIS AND/OR TREATMENT OF ADVERSE DRUG SIDE EFFECTS
RU2018116588A (en) METHOD FOR TREATING CHILDREN OF PATIENTS WITH CHRONIC PYELONEPHRITIS IN ECOLOGICALLY SUSTAINABLE ANAMESIS
UA116484U (en) METHOD OF TREATMENT OF HYPERTENSION WITH METABOLIC SYNDROME
UA115063U (en) METHOD OF TREATMENT OF DOGS WITH PAIN SYNDROME IN PANCREATITIS
UA117618U (en) METHOD OF TREATMENT OF SLEEP DISEASE WITH EXPRESSIVE PAIN SYNDROME
AR114012A1 (en) METHOD OF PROVIDING CELIPROLOL THERAPY TO A PATIENT
UA89203U (en) Method for correcting vegetative dysfunction in children and adolescents with secondary cardiomyopathy
MD918Y (en) Method for treating enteroviral meningitis in children
UA117589U (en) METHOD OF TREATMENT OF CHRONIC CATALOGIC GINGUITIS IN CHILDREN ON DIABETES OF DIABETES